Precision Medicine World Conference 2018: AI in Precision Medicine
Margaretta Colangelo
Leading AI Analyst | Speaker | Writer | AI Newsletter 57,000+ subscribers
Precision Medicine takes into account individual variability in genes, environment, and lifestyle to provide humans with personalized medical care.
The Precision Medicine World Conference in Silicon Valley in January 2018 was an exciting conference focused on AI in healthcare. CEOs of cutting edge companies from around the world came together to discuss how they are using techniques such as computer vision, deep learning and machine learning to make big advances in medicine from drug discovery to patient diagnosis and treatment. Attendees had an opportunity to learn about the latest developments in Precision Medicine and cutting-edge new strategies that are changing how patients are treated.
AI and Data Science Company Showcase
Margaretta Colangelo was the Master of Ceremonies for the AI and Data Science Company Showcase at PMWC. This was the first time that the PMWC included an AI and Data Science Company Showcase in their program. The following are profiles of companies that presented in the AI Showcase. I am an advisor to several of the presenting companies.
All4Cure is building a patient driven database for health care to bring worldwide expertise to bear on the problems of an individual cancer patient (all for one), while using their experiences to advance our ability to understand and treat cancer (one for all).
Altoida develops digital biomarker technologies that collect functional and cognitive biomarkers to classify the risk for Alzheimer’s Disease up to six years prior it’s onset at higher accuracy rates than today’s gold standard biomarkers.
Arterys builds intelligent, easy to use software to make imaging accurate and data driven. Cloud super computation and AI is utilized to aggregate and learn from worldwide data, and create applications expedite image interpretation, and increase consistency across clinicians.
Ayasdi develops enterprise-grade, machine intelligent applications for the healthcare, financial services and the public sector. Powered by breakthroughs in both mathematics and computer science, the company’s software platform has already solved some of the world’s most complex challenges.
Bay Labs is developing breakthrough technologies by applying deep learning?to cardiovascular imaging and care to combat heart disease, the leading cause of death worldwide.
Berg Analytics' innovative machine learning platform,?bAIcis?, uses powerful AI technology to deliver new insights and drive better outcomes for healthcare companies and their patients.
Biodesix is a molecular diagnostics company advancing the development of innovative, multi-omic blood tests in oncology to enable precision medicine. Biodesix uses applied machine learning to develop diagnostic tests that identify patients who may benefit from immunotherapies.
Cognoa - website @CognoaInc
Cognoa utilizes machine leaning to help diagnosis neurobehavioral and developmental disorders in children. Clinically validated in multi-center trials, and used by almost 300,000 families, Cognoa is revolutionizing how parents and clinicians evaluate and support child development.
CureMetrix develops CAD that Works? to empower radiologists, support their patients and reduce costs while improving clinical outcomes. The company is developing physics-based AI solutions to help radiologists get more accurate readings of breast images.
Data4Cure actively mines thousands of public and proprietary datasets and millions of biomedical publications to discover genes, pathways and networks underlying disease and treatment response, and merges diverse pieces of evidence to increase statistical power and facilitating continuous translation of data to knowledge.
Doc.ai is a computational linguistics company building a robo-doctor for quantified biology that follows biological markers across the OMICS. Doc.ai recently started a successful ICO to deploy its AI on the Blockchain based Neuron network designed to collect, predict and change health outcomes for patients and providers.
e-Therapeutics is developing a unique and powerful computer-based discovery engine based on a specialized approach to network biology. This novel methodology allows for the discovery of new and better drugs in a more efficient and effective way.
Exscientia automates drug design using AI driven systems that actively learn best practices from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters.
Freenome is an AI biotech company, creating tools that empower people to detect, diagnose, and treat their diseases, such as cancer.
GNS Healthcare solves healthcare’s matching problem by providing technology, services, and solutions that precisely match drugs, medical procedures, care management programs, and medical devices to individuals to slow disease progression, reduce adverse events, and optimize therapeutic effectiveness.
Good AI Lab is on a mission to scale AI by building the infrastructure and ecosystem to make AI easier and more accessible to any researcher.
领英推荐
InSilico Medicine provides advanced deep learning solutions, custom drug discovery engines, custom biomarker discovery, and new tools for aging research to academia, pharmaceutical and cosmetics companies including the licensing of 827 drug-disease predictions and biomarkers.
Luminata provides next-generation predictive AI to leading health plans and their healthcare provider networks through its flagship Data-as-a-Solution offering, the Lumiata Matrix Suite.
Lunit develops advanced software for medical data analysis and interpretation via cutting-edge deep learning technology to help physicians make accurate, consistent, and efficient clinical decisions and diagnoses through data-driven imaging biomarker technology. In 2017 Lunit was named on CB Insights #AI100 list as one of the 100 most promising private AI companies globally.
Medimsight is the first cloud based medical imaging platform for whole body imaging biomarkers and the first worldwide computer-aided diagnosis marketplace. Using Medimsight, users can send, receive, visualize, share and analyze medical images using machine learning and big data analytics on the Medimsight cloud and receive DICOM medical imaging data as well as PDF reports and 3D representations of tissues.
Mendelai's proprietary matching system uses AI that understands the unstructured, natural language content within medical documents to match cancer patients with clinical trials.
N-of-One is a molecular decision support company providing clinicians with the most concise, accurate and clinically meaningful interpretation of molecular test results.
Numerate applies a novel AI based platform to small molecule chemical design challenges to increase speed, reduce cost, and generate a valuable portfolio of drug programs.
NuMedii is revolutionizing drug discovery by translating big data into pipeline drug candidates with a higher probability of success.
Owkin uses AI to make accurate medical predictions. Owkin builds mathematical models and algorithms that interpret omics, visual data, biostatisitics and patient profiles. This Collaborative Intelligence helps connect dots and data to augment researchers' and doctors' capabilities.
PathAI integrates expertise in machine learning, anatomic pathology, and molecular pathology to create faster, cheaper, and more accurate?pathologic diagnoses.
Recursion Pharmaceuticals is discovering transformative new treatments by leveraging the speed of automation with the intelligence of computers. It's drug discovery at unprecedented?pace.
SkinVision uses mobile technology to capture images of skin lesions and uses machine learning to identify skin cancer in the images. The platform confirms with a personal follow up to customers with proper advice what to do next. By helping detect skin cancer early, the platform saves lives while reducing cost in the health system.
Sophia Genetics develops SOPHiA Artificial Intelligence, a universal technology for genomic data analysis. By enabling the rapid adoption of genomic research worldwide, turning data into actionable insights, and sharing knowledge through its community, SOPHiA Genetics is delivering on the promise of democratizing Data-Driven Medicine.
SRI International is a research center headquartered in Menlo Park, California, working primarily in advanced technology and systems, biosciences, computing, and education. SRI brings its innovations to the marketplace through technology licensing, spin-off ventures and new product solutions.
Standigm applies cutting-edge AI technologies to drug discovery and development. AI and human biology experts team up to build real-world AI models to enhance and accelerate drug discovery and to reveal drug patterns and potential candidates.
twoXAR is an AI-driven drug discovery company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships.
Viome uses AI to analyze gut organisms to determine the best diet for achieving and maintaining ideal weight and optimum health.?The gut microbiome has been implicated in many chronic conditions, including diabetes, obesity, Alzheimer’s, Parkinson’s, coronary artery disease, psoriasis, lupus, and autism. By taking care of their microbiome, people can maximize wellness and potentially prevent disease.
Zogenix develops therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
Copyright ? 2018 Margaretta Colangelo. All Rights Reserved.
This article was written by?Margaretta Colangelo.?Margaretta is a leading AI analyst based in San Francisco. She serves on the advisory board of the AI Precision Health Institute at the University of Hawai?i?Cancer Center.?@realmargaretta